LITTLE ELM, TEXAS, March 7 /CNW/ - Retractable Technologies, Inc. (AMEX:
RVP), a leading maker of safety needle devices, announced today that
Queensland Health, a department within the Queensland government, has awarded
Retractable a one-year contract to supply its VanishPoint(R) automated
retraction syringes to all of Queensland Health's 202 acute care facilities.
The contract, which is effective immediately and renewable for two years,
follows a successful two-year clinical study at Princess Alexandra Hospital in
Brisbane, Australia, Queensland's capital. Virtually all of the healthcare
facilities in Queensland and in Australia's five other states are
VanishPoint(R) products are distributed in Australia by Brisbane-based
Scientific Educational Supplies Pty Ltd.
Retractable Technologies, Inc. manufactures and markets VanishPoint(R)
automated retraction safety syringes and blood collection devices, which
virtually eliminate health care worker exposure to accidental needlestick
injuries. These revolutionary devices use a patented friction ring mechanism
that causes the contaminated needle to retract automatically from the patient
into the barrel of the device, a feature that is designed to prevent reuse.
VanishPoint(R) safety needle devices are distributed by various specialty and
general line distributors. For more information on Retractable, visit our Web
site at www.vanishpoint.com.
Forward-looking statements in this press release are made pursuant to the
safe harbor provision of the Private Securities Litigation Reform Act of 1995
and reflect the Company's current views with respect to future events. The
Company believes that the expectations reflected in such forward-looking
statements are accurate. However, the Company cannot assure you that such
expectations will materialize. The Company's actual future performance could
differ materially from such statements.
Factors that could cause or contribute to such differences include, but
are not limited to: the impact of dramatic increases in demand; the Company's
ability to maintain and quickly increase its production capacity in the event
of a dramatic increase in demand; the Company's ability to access the market;
the Company's ability to decrease production costs; the Company's ability to
continue to finance research and development as well as operations and
expansion of production; the increased interest of other larger market
players, specifically Becton Dickinson and Company, Inc., in providing safety
needle devices to their customers; and other risks and uncertainties that are
detailed from time to time in the Company's periodic reports filed with the
Securities and Exchange Commission.
For further information:
For further information: Retractable Technologies, Inc. Investor
Contact: Douglas W. Cowan, 888-806-2626 or 972-294-1010 Vice President and
Chief Financial Officer email@example.com or Media Contact: Phillip
L. Zweig, 212-490-0811 or 214-912-7415 Communications Director firstname.lastname@example.org
or Distributor Contact (Australia) Richard De Vries President Scientific
Educational Supplies Pty Ltd. Brisbane, Queensland, Australia 0738-496-454
(office) 1-800-656-434 (toll free) 0733-497-091 (fax) 0428-747-884 (cell)